---
category: news
title: "Kiromic Announces Submission of Two IND Applications for PD1 Gamma-delta CAR - T cell Therapy with the FDA"
excerpt: "Kiromic BioPharma (\"the Company\") (NASDAQ:KRBP), a target discovery and gene-editing company utilizing artificial intelligence and its proprietary ... PD1 Gamma-delta CAR (PD1-GDT CAR) T cell therapy is a novel method for \"off-the-shelf\" allogeneic CAR ..."
publishedDateTime: 2020-12-17T17:45:00Z
originalUrl: "https://www.benzinga.com/pressreleases/20/12/b18840129/kiromic-announces-submission-of-two-ind-applications-for-pd1-gamma-delta-car-t-cell-therapy-with-t"
webUrl: "https://www.benzinga.com/pressreleases/20/12/b18840129/kiromic-announces-submission-of-two-ind-applications-for-pd1-gamma-delta-car-t-cell-therapy-with-t"
ampWebUrl: "https://amp.benzinga.com/amp/content/18840129"
cdnAmpWebUrl: "https://amp-benzinga-com.cdn.ampproject.org/c/s/amp.benzinga.com/amp/content/18840129"
type: article
quality: 21
heat: 21
published: false

provider:
  name: Benzinga.com
  domain: benzinga.com

topics:
  - AI in Healthcare
  - AI

secured: "x9rCleH7NrJ3tHJvbzMhS4elHKEMrmq7dkw/OIcyjnqquYl/Lgr7IDuFk6Bl9iiaoawrWRk+jen7QjgaE0/iU6lFP/uYiLAcb4sEEbKlKIU11y+w9IX3oaCJIpm2kbf/G3unV0qHwT0ObYW7nOQhEFmEjxWpatmcWU3TePP2QNn8/H/GvIa3/t+BpCht+n4XxZdEv3rKcabeJlSKaOe8AGGsglnYVO6+f+yQK6OpFK3lrb8fuqXWwgu/x5ZSngnrjWAB9+H8dLLequGOjzSAnw6Q73ABD0V2w9KIO6GZQeC3Pjoh2cPAt4aNQUlKSurHKieBhRBbaGt6gTjte8ogpiaRMzXLRk+iiQepQQu9kWY=;qp6yOhFa8yR2VQ16fjgr1g=="
---

